Skip to main content
. 2022 Oct 21;41:309. doi: 10.1186/s13046-022-02479-y

Fig. 7.

Fig. 7

MET-CAR-T therapeutic activity in experimental tumors overexpressing the MET receptor. (A) Caki-1 tumor growth in NOD-SCID mice treated with 107 MET-CAR-T by intravenous injection on days 4, 7, and 11. (B) GTR-210 tumor growth in NOD-SCID mice treated with 107 MET-CAR-T by intravenous injection on day 6. Vehicle: PBS; NTD: Not-transduced T cells; #948/#949: MET-CAR-T. Bars: Standard Error of the Mean. Statistical significance between Vehicle and MET-CAR-T was calculated by Two-way Anova, corrected Bonferroni. Stars indicated P values: ****, P ≤ 0.0001